0000899243-20-022418.txt : 20200814 0000899243-20-022418.hdr.sgml : 20200814 20200814163704 ACCESSION NUMBER: 0000899243-20-022418 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200812 FILED AS OF DATE: 20200814 DATE AS OF CHANGE: 20200814 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Farid Ramy CENTRAL INDEX KEY: 0001797707 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39206 FILM NUMBER: 201105962 MAIL ADDRESS: STREET 1: SCHRODINGER, INC. STREET 2: 120 WEST 45TH STREET, 17TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10036 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Schrodinger, Inc. CENTRAL INDEX KEY: 0001490978 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 954284541 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 120 WEST 45TH STREET STREET 2: 17TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10036 BUSINESS PHONE: 503-299-1150 MAIL ADDRESS: STREET 1: 120 WEST 45TH STREET STREET 2: 17TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10036 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-08-12 0 0001490978 Schrodinger, Inc. SDGR 0001797707 Farid Ramy C/O SCHRODINGER, INC., 120 WEST 45TH STREET, 17TH FLOOR NEW YORK NY 10036 1 1 0 0 See Remarks Common Stock 2020-08-12 4 S 0 1000 64.874 D 333432 D Common Stock 2020-08-12 4 S 0 3431 66.0103 D 330001 D Common Stock 2020-08-12 4 S 0 34416 66.9178 D 295585 D Common Stock 2020-08-12 4 S 0 36203 67.7233 D 259382 D Common Stock 2020-08-12 4 S 0 4950 68.5417 D 254432 D Common Stock 2020-08-13 4 S 0 18804 69.8265 D 235628 D Common Stock 2020-08-13 4 S 0 15767 70.6228 D 219861 D Common Stock 2020-08-13 4 S 0 15429 71.4888 D 204432 D These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 19, 2020. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $64.36 to $65.33, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) through (9) of this Form 4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $65.37 to $66.35, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $66.38 to $67.37, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $67.38 to $68.35, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $68.38 to $68.78, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $69.25 to $70.235, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $70.26 to $71.19, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $71.29 to $71.98, inclusive. President and Chief Executive Officer /s/ Yvonne Tran, as attorney-in-fact for Ramy Farid 2020-08-14